Description
This volume provides a comprehensive review of China's healthcare system and policy reforms in the context of the global economy. Following a value-chain framework, the 16 chapters cover the payers, the providers, and the producers (manufacturers) in China's system. It also provides a detailed analysis of the historical development of China's healthcare system, the current state of its broad reforms, and the uneasy balance between China's market-driven approach and governmental regulation. Most importantly, it devotes considerable attention to the major problems confronting China, including chronic illness, public health, and long-term care and economic security for the elderly. Burns and Liu have assembled the latest research from leading health economists and political scientists, as well as senior public health officials and corporate executives, making this book an essential read for industry professionals, policymakers, researchers, and students studying comparative health systems across the world.
Table of Contents
Foreword William C. Hsiao; Preface; Acknowledgements; Part I. Introduction: Analytic Framework, History, and Public Health: 1. China's healthcare industry: a system perspective Lawton Robert Burns and Gordon Liu; 2. History of China's healthcare system Lawton Robert Burns and Yanzhong Huang; 3. China's public health system and infrastructure Xiaofeng Liang and Lawton Robert Burns; Part II. Healthcare Reform: 4. Epidemiological transition and health system reforms in China Gordon Liu and Sam Krumholz; 5. China's healthcare reform: status and outlook Claudia Suessmuth-Dyckerhoff and Florian Then; 6. The challenge of non-communicable diseases (NCDs) in China: government responses and opportunities for reform Tsung-Mei Cheng; Part III. Healthcare Providers: 7. China's physician and nurse workforce Lawton Robert Burns; 8. China's hospital sector Jerry LaForgia and Winnie Yip; 9. United family healthcare (Chindex International): a case study Vanessa Folkerts and Roberta Lipson; 10. Providing and financing elder care in China John Whitman and Lawton Robert Burns; Part IV. Insurers and Reimbursement: 11. Health insurance in China Ambar LaForgia and Lawton Robert Burns; 12. Health insurance and chronic disease control: quasi-experimental evidence from hypertension in rural China Karen Eggleston, Kate Bundorf, Margaret Triyana, Yan Wang and Sen Zhou; 13. Drug pricing and health technology assessment in China and other Asian markets Gordon Liu, Nan Luo and Zhongyun Zhao; Part V. Product Manufacturers: 14. China's pharmaceutical sector Rachel Lee and Lawton Robert Burns; 15. China's medical technology sector James Deng and Lawton Robert Burns; 16. Life sciences investment and biotechnology in China Stephen Sammut and Lawton Robert Burns; Index.
